Acrivon Therapeutics (ACRV, $6.25) is predicted by A.I.dvisor to grow by to $6.38 or more within the next week. With its winning streak extending for a consecutive week, ACRV is expected to continue climbing following the week-long Uptrend ― the odds of an Uptrend continuation are